Control of NK Cell Activation by Immune Checkpoint Molecules.
about
Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma.Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.Immune checkpoint receptors: homeostatic regulators of immunity.Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals
P2860
Control of NK Cell Activation by Immune Checkpoint Molecules.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Control of NK Cell Activation by Immune Checkpoint Molecules.
@en
Control of NK Cell Activation by Immune Checkpoint Molecules.
@nl
type
label
Control of NK Cell Activation by Immune Checkpoint Molecules.
@en
Control of NK Cell Activation by Immune Checkpoint Molecules.
@nl
prefLabel
Control of NK Cell Activation by Immune Checkpoint Molecules.
@en
Control of NK Cell Activation by Immune Checkpoint Molecules.
@nl
P2860
P921
P356
P1476
Control of NK Cell Activation by Immune Checkpoint Molecules.
@en
P2093
Asma Beldi-Ferchiou
Sophie Caillat-Zucman
P2860
P356
10.3390/IJMS18102129
P407
P577
2017-10-12T00:00:00Z